Skip to content

Yoga for Veterans With CLBP

Yoga Therapy to Improve Function Among Veterans With Chronic Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524158
Enrollment
152
Registered
2015-08-14
Start date
2013-04-30
Completion date
2016-12-31
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

Yoga, Mind-Body Therapies, Chronic Low Back Pain, Military Veterans, VA patients

Brief summary

Chronic low back pain (CLBP) is a prevalent condition among VA patients, but many current treatment options have limited effectiveness. In addition to chronic pain, people with chronic low back pain experience increased disability, psychological symptoms such as depression, and reduced health-related quality of life. This randomized controlled study will examine the impact of yoga therapy for improving function and decreasing pain in VA patients with chronic low back pain. Although not every VA patient with chronic low back pain will choose to do yoga, it is an inexpensive treatment modality that is increasingly appealing to many VA patients. If yoga is effective, it could become an additional low-cost option that the VA can offer to better serve Veterans with chronic low back pain.

Interventions

BEHAVIORALYoga Therapy for CLBP

Classes begin with a few minutes of simple seated breathing exercises. Depending on their mobility, participants can sit either on the floor or on a chair. This is followed by gentle warm-up stretches. Participants are then led through a series of standing postures, seated postures and floor postures. The difficulty of the poses will gradually increase over the duration of the 12 weeks, and appropriate modifications are offered to participants whenever needed. Deep and rhythmic breathing will be emphasized throughout. Each class will end with a supine resting pose.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has a VA primary care provider * Diagnosis of chronic low back pain \> 6 months * Willing to attend a yoga program or be assigned to delayed treatment with yoga * Willing to complete 4 assessments * English Literacy * Has not begun new pain treatments or medications in the past month * Willing to not change pain treatments (e.g., discontinue a treatment; increase medication dose) during the 12-week intervention period unless medically necessary

Exclusion criteria

* back surgery within the last 12 months * back pain due to specific systemic problem (eg, lupus, scleroderma, fibromyalgia) * morbid obesity (BMI \> 40) * Significant sciatica or nerve compression \< 3 months or chronic lumbar radicular pain \> 3 months * Unstable, serious coexisting medical illness (eg, CHF, cancer, COPD, morbid obesity; dementia) * Unstable, serious psychiatric illness (e.g., unmanaged psychosis, active substance dependence) * Insufficient data to rule out acute, metastatic disease, (unless primary care physician approves) * Attended or practiced yoga \> 1x in the last 12 months * Positive Romberg test (with or without sensory neuropathy)

Design outcomes

Primary

MeasureTime frameDescription
Roland-Morris Disability Questionnairebaseline to 12 weeksThe primary outcomes is the change in Roland-Morris Disability Questionnaire (RMDQ) score between baseline and 12-weeks. The questionnaire consists of 24 questions that ask about back pain-related functional limitations experienced for a variety of daily activities . Scores can range from 0-24. Higher scores indicate more impairment, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement. The scale has been shown to be reliable and is well validated. It has been used in another yoga RCT, allowing for comparisons.

Secondary

MeasureTime frameDescription
Change From Baseline in Pain Intensity - Brief Pain Inventory at 6 Monthsbaseline to 6 monthsThe short version of the Brief Pain Inventory (BPI) is a self-rated questionnaire designed to assess the severity of pain and the impact of pain on daily functions in the past day and week. The BPI takes about 5 minutes to complete and has been validated with low back pain patients. It has been shown to respond to both behavioral and pharmacological pain interventions. The BPI measures severity of pain, impact of pain on daily function, location of pain, pain medications, and amount of pain relief. Items are answered utilizing a scoring algorithm, with the mean of the 4 severity items used as measures of pain severity. Scores range from 0-10, with higher scores indicating more pain, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement.
Change From Baseline Pain Interference - Brief Pain Inventory at 12 Weeksbaseline to 12 weeksThe short version of the Brief Pain Inventory (BPI) is a self-rated questionnaire designed to assess the severity of pain and the impact of pain on daily functions in the past day and week. The BPI takes about 5 minutes to complete and has been validated with low back pain patients. It has been shown to respond to both behavioral and pharmacological pain interventions. The BPI measures severity of pain, impact of pain on daily function, location of pain, pain medications, and amount of pain relief. Items are answered utilizing a scoring algorithm, with the mean of the 7 interference items used a as a measure of pain interference. Scores range from 0-10, with higher scores indicating more pain, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement.
Change From Baseline - Fatigue Severity Scale (FSS) at 12 Weeksbaseline to 12 weeksFatigue (absence of energy) will be measured with the Fatigue Severity Scale (FSS). The FSS is a self-administered instrument developed to assess the impact and severity of fatigue. It consists of 9 items describing the functional impact of fatigue on daily life rated on a scale from 1 (strongly disagree) to 7 (strongly agree) with the total fatigue score ranging from 9-63 or an average score ranging from 1.0-7.0. Higher scores reflect greater fatigue severity and less energy.
Change From Baseline - SF12 PCS at 12 Weeksbaseline to 12 weeksHealth-related quality of life will be measured using the Short-form 12 (SF12). Based on the longer SF-36, the SF-12 was developed with the objective of finding a short yet meaningful measure of generic HRQOL or global health status. The 12 items were selected from the SF-36 and tested through a series of stages. The PCS-12 and MCS-12 show similar levels of precision to the summary scores derived from the longer 36-item measure. PCS-12 and MCS-12 scores are transformed to a 0 to 100, with higher scores indicating better quality of life.
Change From Baseline - SF12 MCS at 12 Weeksbaseline to 12 weeksMental Component Scale - Health-related quality of life will be measured using the Short-form 12 (SF12). Based on the longer SF-36, the SF-12 was developed with the objective of finding a short yet meaningful measure of generic HRQOL or global health status. The 12 items were selected from the SF-36 and tested through a series of stages. The PCS-12 and MCS-12 show similar levels of precision to the summary scores derived from the longer 36-item measure. PCS-12 and MCS-12 scores are transformed to a 0 to 100, with higher scores indicating better quality of life.
Change From Baseline - EuroQOL 5D (EQ5D) at 12 Weeksbaseline to 12 weeksThe EQ5D is a preference-based measure of health-related quality of life. The measure produces a single score ranging from 0 (death) to 1.00 (optimal health). Scores can be integrated with time to calculate Quality Adjusted Life Years.
Change From Baseline - Center for Epidemiologic Studies Short Depression Scale (CES-D 10) at 12 Weeksbaseline to 12 weeksDepression will be assessed using the Center for Epidemiologic Studies Short Depression Scale (CES-D 10). Derived from the full CES-D, there are 10 items that ask about the frequency of mood symptoms, rated on a 4-point Likert scale ranging from 0 (Never) to 3 (All of the Time). Scores range from 0 to 30, and higher scores indicate greater depression. A number of items are reverse-scored and a score of 10 or greater is considered depressed. Normative data on people with assorted chronic illnesses are available for comparisons.
Change From Baseline in Pain Intensity - Brief Pain Inventory at 12 Weeksbaseline to 12 weeksThe short version of the Brief Pain Inventory (BPI) is a self-rated questionnaire designed to assess the severity of pain and the impact of pain on daily functions in the past day and week. The BPI takes about 5 minutes to complete and has been validated with low back pain patients. It has been shown to respond to both behavioral and pharmacological pain interventions. The BPI measures severity of pain, impact of pain on daily function, location of pain, pain medications, and amount of pain relief. Items are answered utilizing a scoring algorithm, with the mean of the 4 severity items used as measures of pain severity. Scores range from 0-10, with higher scores indicating more pain, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement.
Change From Baseline - Pittsburgh Sleep Quality Index (PSQI) at 12 Weeksbaseline to 12 weeksThe PSQI is a validated measure of sleep quality. The global PSQI score has a range of 0-21, with higher scores indicating worse sleep quality.
Change From Baseline - Self-efficacy for Managing Low Back Pain at 12 Weeksbaseline to 12 weeksSelf-efficacy for controlling CLBP reflects levels of confidence in the ability to influence the intensity of back pain symptoms and the impact that CLBP has on daily life. The questions are based on self-efficacy items developed for the Medical Outcomes Study in mixed chronic diseases. The wording of the items has been adapted to be specific to CLBP. The measure consists of 6 items, rated on a 6-point Likert scale, with each item ranging from 0-10. The total score is the mean of the 6 items with higher scores indicating greater self-efficacy for managing CLBP.
Attendance/ Home Practice12 weeksTwo indicators of the amount of yoga practiced by each participant will be used. Actual attendance of yoga sessions will be assessed using VA medical record data. Attendance can range from 0-24 sessions attended for those participants randomized to yoga. Self-reported practice of yoga at home will be assessed using a weekly participant yoga log. The self-report yoga log assesses whether they practiced yoga each day, the amount of minutes practiced, the use of instructions, the difficulty of poses, and the estimated level of physical activity or exertion.
Change From Baseline - Range of Motion - Flexion at 12 Weeksbaseline to 12 weeksSpinal Range of Motion (ROM) will be measured using a Saunders Digital Inclinometer, a portable device which isolates lumbar ROM. The device is placed along the spine and uses a precise optical angular scanner. Forward bend angle measures how far forward and downward a person can bend at the waist, from a fully erect and/or normal standing position. The value typically ranges from 0-180 degrees, with higher values indicating greater flexibility.
Change From Baseline - Grip Strength at 12 Weeksbaseline to 12 weeksGrip strength in both hands of each participant will be measured using an adjustable, hydraulic grip strength dynamometer (Jamar Hydraulic Hand Dynamometer). Three trials will be conducted for each hand. In cases of current pain flare-ups or recent procedures to a hand or wrist, the affected hand is not tested, and the result of the one other hand is used. If both hands are used the best performance of two trials will be selected for each side, and the average of the left and right hand will be used for analysis. The value measured is pounds of force exerted and typically ranges from 0 - 150 lbs, with higher numbers indicating greater grip strength.
Change From Baseline - Lower Limb Strength and Balance - Eyes Open at 12 Weeksbaseline to 12 weeksThe Single Leg Stance (SLS) is a commonly used measure of both lower leg strength and balance. A total of four trials were conducted - left and right leg with both eyes open and eyes closed. Each trial will be timed from the moment the participant lifts one foot off the floor until the moment they need to place it on the floor again. If the participant is able to stand on one leg for 60 seconds the trial will be stopped and they will be asked to switch side. Values range from 0 - 60 seconds with greater values indicating better balance.
Change From Baseline - Lower Spine Stabilization - Core Strength at 12 Weeksbaseline to 12 weeksTime in seconds holding plank position on the elbows.
Change From Baseline - Brief Anxiety Inventory (BAI) at 12 Weeksbaseline to 12 weeksThe Brief Anxiety Inventory (BAI) measures the severity of anxiety symptoms, particularly those that distinguish anxiety from depression. The BAI consists of 21 items, is self-administered and can be completed in 5 to 10 minutes. Items are scored on a scale of 0 to 3 and are summed to generate a total score. Scores range from 0 to 63, and higher scores indicate greater depression.

Countries

United States

Participant flow

Participants by arm

ArmCount
Yoga
The yoga intervention consisted of 2x weekly, 60-minute Hatha Yoga classes for 12 weeks, geared toward a CLBP population. Classes begin with a few minutes of simple seated breathing exercises. Depending on their mobility, participants can sit either on the floor or on a chair. This is followed by gentle warm-up stretches. Participants are then led through a series of standing postures, seated postures and floor postures. The difficulty of the poses will gradually increase over the duration of the 12 weeks, and appropriate modifications are offered to participants whenever needed. Deep and rhythmic breathing will be emphasized throughout. Each class will end with a supine resting pose.
75
Delayed Treatment Control - Usual Care
Participants randomly assigned to this arm are allowed to continue all existing treatments. Participants and their primary care physician are asked to not change treatments unless medically necessary. participants are asked to not do yoga for 6 months. They are given free yoga and a yoga mat after 6 months.
75
Total150

Withdrawals & dropouts

PeriodReasonFG000FG001
12-weeks AssessmentLost to Follow-up1812
12-weeks AssessmentWithdrawal by Subject11
6-month AssessmentLost to Follow-up2120
6-month AssessmentWithdrawal by Subject11

Baseline characteristics

CharacteristicYogaTotalDelayed Treatment Control - Usual Care
Age, Continuous53.3 years
STANDARD_DEVIATION 12.7
53.4 years
STANDARD_DEVIATION 13.3
53.6 years
STANDARD_DEVIATION 13.9
Ethnicity (NIH/OMB)
Hispanic or Latino
15 Participants30 Participants15 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
60 Participants120 Participants60 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Asian
3 Participants9 Participants6 Participants
Race (NIH/OMB)
Black or African American
16 Participants26 Participants10 Participants
Race (NIH/OMB)
More than one race
5 Participants9 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
50 Participants104 Participants54 Participants
Region of Enrollment
United States
75 Participants150 Participants75 Participants
Sex: Female, Male
Female
20 Participants39 Participants19 Participants
Sex: Female, Male
Male
55 Participants111 Participants56 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 750 / 75
other
Total, other adverse events
2 / 750 / 75
serious
Total, serious adverse events
0 / 750 / 75

Outcome results

Primary

Roland-Morris Disability Questionnaire

The primary outcomes is the change in Roland-Morris Disability Questionnaire (RMDQ) score between baseline and 12-weeks. The questionnaire consists of 24 questions that ask about back pain-related functional limitations experienced for a variety of daily activities . Scores can range from 0-24. Higher scores indicate more impairment, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement. The scale has been shown to be reliable and is well validated. It has been used in another yoga RCT, allowing for comparisons.

Time frame: baseline to 12 weeks

Population: Of the 76 participants randomized to each group, 1 participants in each group requested withdrawal of all of their data from the study. Thus, baseline characteristics, outcomes analyses, and outcomes results are reported for 75 participants.

ArmMeasureValue (MEAN)
YogaRoland-Morris Disability Questionnaire-2.05 units on a scale
Delayed Treatment Control - Usual CareRoland-Morris Disability Questionnaire-1.29 units on a scale
p-value: 0.34Mixed Models Analysis
Primary

Roland-Morris Disability Questionnaire

The primary outcome is the change in Roland-Morris Disability Questionnaire (RMDQ) score between baseline, 12-weeks, and 6-months. The questionnaire consists of 24 questions that ask about back pain-related functional limitations experienced for a variety of daily activities . Scores can range from 0-24. Higher scores indicate more impairment, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement. The scale has been shown to be reliable and is well validated. It has been used in another yoga RCT, allowing for comparisons.

Time frame: baseline to 6-months

Population: Of the 76 participants randomized to each group, 1 participants in each group requested withdrawal of all of their data from the study. Thus, baseline characteristics, outcomes analyses, and outcomes results are reported for 75 participants.

ArmMeasureValue (MEAN)
YogaRoland-Morris Disability Questionnaire-3.37 units on a scale
Delayed Treatment Control - Usual CareRoland-Morris Disability Questionnaire-0.89 units on a scale
p-value: 0.003Mixed Models Analysis
Secondary

Attendance/ Home Practice

Two indicators of the amount of yoga practiced by each participant will be used. Actual attendance of yoga sessions will be assessed using VA medical record data. Attendance can range from 0-24 sessions attended for those participants randomized to yoga. Self-reported practice of yoga at home will be assessed using a weekly participant yoga log. The self-report yoga log assesses whether they practiced yoga each day, the amount of minutes practiced, the use of instructions, the difficulty of poses, and the estimated level of physical activity or exertion.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
YogaAttendance/ Home Practice12.28 sessions attendedStandard Error 1.013
Secondary

Change From Baseline - Brief Anxiety Inventory (BAI) at 12 Weeks

The Brief Anxiety Inventory (BAI) measures the severity of anxiety symptoms, particularly those that distinguish anxiety from depression. The BAI consists of 21 items, is self-administered and can be completed in 5 to 10 minutes. Items are scored on a scale of 0 to 3 and are summed to generate a total score. Scores range from 0 to 63, and higher scores indicate greater depression.

Time frame: baseline to 12 weeks

Population: Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Brief Anxiety Inventory (BAI) at 12 Weeks-1.69 units on a scaleStandard Error 1.08
Delayed Treatment Control - Usual CareChange From Baseline - Brief Anxiety Inventory (BAI) at 12 Weeks0.23 units on a scaleStandard Error 0.67
p-value: 0.369ANCOVA
Secondary

Change From Baseline - Center for Epidemiologic Studies Short Depression Scale (CES-D 10) at 12 Weeks

Depression will be assessed using the Center for Epidemiologic Studies Short Depression Scale (CES-D 10). Derived from the full CES-D, there are 10 items that ask about the frequency of mood symptoms, rated on a 4-point Likert scale ranging from 0 (Never) to 3 (All of the Time). Scores range from 0 to 30, and higher scores indicate greater depression. A number of items are reverse-scored and a score of 10 or greater is considered depressed. Normative data on people with assorted chronic illnesses are available for comparisons.

Time frame: baseline to 12 weeks

Population: Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Center for Epidemiologic Studies Short Depression Scale (CES-D 10) at 12 Weeks-1.6 units on a scaleStandard Error 0.549
Delayed Treatment Control - Usual CareChange From Baseline - Center for Epidemiologic Studies Short Depression Scale (CES-D 10) at 12 Weeks-0.63 units on a scaleStandard Error 0.499
p-value: 0.202ANCOVA
Secondary

Change From Baseline - EuroQOL 5D (EQ5D) at 12 Weeks

The EQ5D is a preference-based measure of health-related quality of life. The measure produces a single score ranging from 0 (death) to 1.00 (optimal health). Scores can be integrated with time to calculate Quality Adjusted Life Years.

Time frame: baseline to 12 weeks

Population: Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)
YogaChange From Baseline - EuroQOL 5D (EQ5D) at 12 Weeks0.077 units on a scale
Delayed Treatment Control - Usual CareChange From Baseline - EuroQOL 5D (EQ5D) at 12 Weeks0.018 units on a scale
p-value: <0.1Mixed Models Analysis
Secondary

Change From Baseline - Fatigue Severity Scale (FSS) at 12 Weeks

Fatigue (absence of energy) will be measured with the Fatigue Severity Scale (FSS). The FSS is a self-administered instrument developed to assess the impact and severity of fatigue. It consists of 9 items describing the functional impact of fatigue on daily life rated on a scale from 1 (strongly disagree) to 7 (strongly agree) with the total fatigue score ranging from 9-63 or an average score ranging from 1.0-7.0. Higher scores reflect greater fatigue severity and less energy.

Time frame: baseline to 12 weeks

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Fatigue Severity Scale (FSS) at 12 Weeks-5.29 units on a scaleStandard Error 1.532
Delayed Treatment Control - Usual CareChange From Baseline - Fatigue Severity Scale (FSS) at 12 Weeks0.82 units on a scaleStandard Error 1.172
p-value: <0.01ANCOVA
Secondary

Change From Baseline - Grip Strength at 12 Weeks

Grip strength in both hands of each participant will be measured using an adjustable, hydraulic grip strength dynamometer (Jamar Hydraulic Hand Dynamometer). Three trials will be conducted for each hand. In cases of current pain flare-ups or recent procedures to a hand or wrist, the affected hand is not tested, and the result of the one other hand is used. If both hands are used the best performance of two trials will be selected for each side, and the average of the left and right hand will be used for analysis. The value measured is pounds of force exerted and typically ranges from 0 - 150 lbs, with higher numbers indicating greater grip strength.

Time frame: baseline to 12 weeks

Population: Some participants declined to participate because of injury concern. Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Grip Strength at 12 Weeks-0.30 pounds per sq inchStandard Error 1.59
Delayed Treatment Control - Usual CareChange From Baseline - Grip Strength at 12 Weeks0.62 pounds per sq inchStandard Error 1.17
p-value: 0.92ANCOVA
Secondary

Change From Baseline in Pain Intensity - Brief Pain Inventory at 12 Weeks

The short version of the Brief Pain Inventory (BPI) is a self-rated questionnaire designed to assess the severity of pain and the impact of pain on daily functions in the past day and week. The BPI takes about 5 minutes to complete and has been validated with low back pain patients. It has been shown to respond to both behavioral and pharmacological pain interventions. The BPI measures severity of pain, impact of pain on daily function, location of pain, pain medications, and amount of pain relief. Items are answered utilizing a scoring algorithm, with the mean of the 4 severity items used as measures of pain severity. Scores range from 0-10, with higher scores indicating more pain, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement.

Time frame: baseline to 12 weeks

Population: Of the 76 participants randomized to each group, 1 participants in each group requested withdrawal of all of their data from the study. Thus, baseline characteristics, outcomes analyses, and outcomes results are reported for 75 participants.

ArmMeasureValue (MEAN)
YogaChange From Baseline in Pain Intensity - Brief Pain Inventory at 12 Weeks-0.61 units on a scale
Delayed Treatment Control - Usual CareChange From Baseline in Pain Intensity - Brief Pain Inventory at 12 Weeks0.04 units on a scale
p-value: 0.005Mixed Models Analysis
Secondary

Change From Baseline in Pain Intensity - Brief Pain Inventory at 6 Months

The short version of the Brief Pain Inventory (BPI) is a self-rated questionnaire designed to assess the severity of pain and the impact of pain on daily functions in the past day and week. The BPI takes about 5 minutes to complete and has been validated with low back pain patients. It has been shown to respond to both behavioral and pharmacological pain interventions. The BPI measures severity of pain, impact of pain on daily function, location of pain, pain medications, and amount of pain relief. Items are answered utilizing a scoring algorithm, with the mean of the 4 severity items used as measures of pain severity. Scores range from 0-10, with higher scores indicating more pain, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement.

Time frame: baseline to 6 months

Population: Of the 76 participants randomized to each group, 1 participants in each group requested withdrawal of all of their data from the study. Thus, baseline characteristics, outcomes analyses, and outcomes results are reported for 75 participants.

ArmMeasureValue (MEAN)
YogaChange From Baseline in Pain Intensity - Brief Pain Inventory at 6 Months-0.44 units on a scale
Delayed Treatment Control - Usual CareChange From Baseline in Pain Intensity - Brief Pain Inventory at 6 Months0.15 units on a scale
p-value: 0.013Mixed Models Analysis
Secondary

Change From Baseline - Lower Limb Strength and Balance - Eyes Open at 12 Weeks

The Single Leg Stance (SLS) is a commonly used measure of both lower leg strength and balance. A total of four trials were conducted - left and right leg with both eyes open and eyes closed. Each trial will be timed from the moment the participant lifts one foot off the floor until the moment they need to place it on the floor again. If the participant is able to stand on one leg for 60 seconds the trial will be stopped and they will be asked to switch side. Values range from 0 - 60 seconds with greater values indicating better balance.

Time frame: baseline to 12 weeks

Population: Only a subset agreed to assessment. Some declined if concerned about injury. Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Lower Limb Strength and Balance - Eyes Open at 12 Weeks6.21 secondsStandard Error 2.63
Delayed Treatment Control - Usual CareChange From Baseline - Lower Limb Strength and Balance - Eyes Open at 12 Weeks1.05 secondsStandard Error 1.34
p-value: 0.036ANCOVA
Secondary

Change From Baseline - Lower Spine Stabilization - Core Strength at 12 Weeks

Time in seconds holding plank position on the elbows.

Time frame: baseline to 12 weeks

Population: Only a subset agreed to assessment. Some declined if concerned about injury. Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Lower Spine Stabilization - Core Strength at 12 Weeks18.70 secondsStandard Error 4.15
Delayed Treatment Control - Usual CareChange From Baseline - Lower Spine Stabilization - Core Strength at 12 Weeks10.50 secondsStandard Error 3.28
p-value: 0.071ANCOVA
Secondary

Change From Baseline Pain Interference - Brief Pain Inventory at 12 Weeks

The short version of the Brief Pain Inventory (BPI) is a self-rated questionnaire designed to assess the severity of pain and the impact of pain on daily functions in the past day and week. The BPI takes about 5 minutes to complete and has been validated with low back pain patients. It has been shown to respond to both behavioral and pharmacological pain interventions. The BPI measures severity of pain, impact of pain on daily function, location of pain, pain medications, and amount of pain relief. Items are answered utilizing a scoring algorithm, with the mean of the 7 interference items used a as a measure of pain interference. Scores range from 0-10, with higher scores indicating more pain, and when considering the change from baseline to follow-up assessments, negative scores indicate improvement.

Time frame: baseline to 12 weeks

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline Pain Interference - Brief Pain Inventory at 12 Weeks-0.85 units on a scaleStandard Error 0.245
Delayed Treatment Control - Usual CareChange From Baseline Pain Interference - Brief Pain Inventory at 12 Weeks-0.21 units on a scaleStandard Error 0.217
p-value: 0.044ANCOVA
Secondary

Change From Baseline - Pittsburgh Sleep Quality Index (PSQI) at 12 Weeks

The PSQI is a validated measure of sleep quality. The global PSQI score has a range of 0-21, with higher scores indicating worse sleep quality.

Time frame: baseline to 12 weeks

Population: Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Pittsburgh Sleep Quality Index (PSQI) at 12 Weeks-1.56 units on a scaleStandard Error 0.43
Delayed Treatment Control - Usual CareChange From Baseline - Pittsburgh Sleep Quality Index (PSQI) at 12 Weeks-0.082 units on a scaleStandard Error 0.41
p-value: 0.5ANCOVA
Secondary

Change From Baseline - Range of Motion - Flexion at 12 Weeks

Spinal Range of Motion (ROM) will be measured using a Saunders Digital Inclinometer, a portable device which isolates lumbar ROM. The device is placed along the spine and uses a precise optical angular scanner. Forward bend angle measures how far forward and downward a person can bend at the waist, from a fully erect and/or normal standing position. The value typically ranges from 0-180 degrees, with higher values indicating greater flexibility.

Time frame: baseline to 12 weeks

Population: Only a subset agreed to assessment. Some declined if concerned about injury. Main outcomes were conducted using linear modeling across multiple time points. This analysis used only 2 time points, with attrition from the 12-week assessment, and incomplete answers accounting for reduced sample size.

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Range of Motion - Flexion at 12 Weeks7.41 degrees flexionStandard Error 2.56
Delayed Treatment Control - Usual CareChange From Baseline - Range of Motion - Flexion at 12 Weeks2.65 degrees flexionStandard Error 2.24
p-value: 0.071ANCOVA
Secondary

Change From Baseline - Self-efficacy for Managing Low Back Pain at 12 Weeks

Self-efficacy for controlling CLBP reflects levels of confidence in the ability to influence the intensity of back pain symptoms and the impact that CLBP has on daily life. The questions are based on self-efficacy items developed for the Medical Outcomes Study in mixed chronic diseases. The wording of the items has been adapted to be specific to CLBP. The measure consists of 6 items, rated on a 6-point Likert scale, with each item ranging from 0-10. The total score is the mean of the 6 items with higher scores indicating greater self-efficacy for managing CLBP.

Time frame: baseline to 12 weeks

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - Self-efficacy for Managing Low Back Pain at 12 Weeks0.26 units on a scaleStandard Error 0.27
Delayed Treatment Control - Usual CareChange From Baseline - Self-efficacy for Managing Low Back Pain at 12 Weeks-0.48 units on a scaleStandard Error 0.21
p-value: 0.067ANCOVA
Secondary

Change From Baseline - SF12 MCS at 12 Weeks

Mental Component Scale - Health-related quality of life will be measured using the Short-form 12 (SF12). Based on the longer SF-36, the SF-12 was developed with the objective of finding a short yet meaningful measure of generic HRQOL or global health status. The 12 items were selected from the SF-36 and tested through a series of stages. The PCS-12 and MCS-12 show similar levels of precision to the summary scores derived from the longer 36-item measure. PCS-12 and MCS-12 scores are transformed to a 0 to 100, with higher scores indicating better quality of life.

Time frame: baseline to 12 weeks

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - SF12 MCS at 12 Weeks-0.04 units on a scaleStandard Error 1.024
Delayed Treatment Control - Usual CareChange From Baseline - SF12 MCS at 12 Weeks-0.43 units on a scaleStandard Error 0.772
p-value: 0.66ANCOVA
Secondary

Change From Baseline - SF12 PCS at 12 Weeks

Health-related quality of life will be measured using the Short-form 12 (SF12). Based on the longer SF-36, the SF-12 was developed with the objective of finding a short yet meaningful measure of generic HRQOL or global health status. The 12 items were selected from the SF-36 and tested through a series of stages. The PCS-12 and MCS-12 show similar levels of precision to the summary scores derived from the longer 36-item measure. PCS-12 and MCS-12 scores are transformed to a 0 to 100, with higher scores indicating better quality of life.

Time frame: baseline to 12 weeks

ArmMeasureValue (MEAN)Dispersion
YogaChange From Baseline - SF12 PCS at 12 Weeks4.40 units on a scaleStandard Error 1.042
Delayed Treatment Control - Usual CareChange From Baseline - SF12 PCS at 12 Weeks0.58 units on a scaleStandard Error 0.853
p-value: 0.01ANCOVA

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026